Maze Therapeutics, Inc.

MAZE

—

Advanced chart & tools →

Maze Therapeutics, Inc.MAZE

$0.00

+$0.00(+NaN%)Past Year

Jun 25Sep 25Dec 25Mar 26Jun 26

Key statistics

Market cap

—

P/E ratio

—

EPS (diluted)

$-3.05

Dividend yield

0.00%

Dividend / share

$0.00

Revenue

$167.50M

Net income

$-131.12M

Net margin

-78.3%

Gross margin

—

Dividends & financials

Maze Therapeutics, Inc. (MAZE) reported revenue of $167.50M and net income of $-131.12M, or $-3.05 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.